{"id":"https://openalex.org/W2047446972","doi":"https://doi.org/10.1016/s0031-6989(84)80099-5","title":"Effect of oral mesoglycan on plasma lipoprotein concentration and on lipoprotein lipase activity in primary hyperlipoproteinemia","display_name":"Effect of oral mesoglycan on plasma lipoprotein concentration and on lipoprotein lipase activity in primary hyperlipoproteinemia","publication_year":1984,"publication_date":"1984-01-01","ids":{"openalex":"https://openalex.org/W2047446972","doi":"https://doi.org/10.1016/s0031-6989(84)80099-5","mag":"2047446972","pmid":"https://pubmed.ncbi.nlm.nih.gov/6230680"},"language":"en","primary_location":{"id":"doi:10.1016/s0031-6989(84)80099-5","doi":"https://doi.org/10.1016/s0031-6989(84)80099-5","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0031-6989(84)80099-5","pdf_url":null,"source":{"id":"https://openalex.org/S129439886","display_name":"Pharmacological Research Communications","issn_l":"0031-6989","issn":["0031-6989","1879-2936"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310319955","host_organization_name":"Academic Press","host_organization_lineage":["https://openalex.org/P4310319955","https://openalex.org/P4310320990"],"host_organization_lineage_names":["Academic Press","Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacological Research Communications","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5029125030","display_name":"A. Postiglione","orcid":"https://orcid.org/0000-0001-6411-6529","observed_orcids":["https://orcid.org/0000-0001-6411-6529"]},"institutions":[{"id":"https://openalex.org/I71267560","display_name":"University of Naples Federico II","ror":"https://ror.org/05290cv24","country_code":"IT","type":"education","lineage":["https://openalex.org/I71267560"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"A. Postiglione","raw_affiliation_strings":["Institute of Internal Medicine and Metabolic Disease, Clinica Medica II, 2nd Faculty of Medicine, University of Naples, Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Internal Medicine and Metabolic Disease, Clinica Medica II, 2nd Faculty of Medicine, University of Naples, Naples, Italy","institution_ids":["https://openalex.org/I71267560"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109456174","display_name":"Barbieri Simone","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I71267560","display_name":"University of Naples Federico II","ror":"https://ror.org/05290cv24","country_code":"IT","type":"education","lineage":["https://openalex.org/I71267560"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"B. De Simone","raw_affiliation_strings":["Institute of Internal Medicine and Metabolic Disease, Clinica Medica II, 2nd Faculty of Medicine, University of Naples, Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Internal Medicine and Metabolic Disease, Clinica Medica II, 2nd Faculty of Medicine, University of Naples, Naples, Italy","institution_ids":["https://openalex.org/I71267560"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049354882","display_name":"Paolo Rubba","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I71267560","display_name":"University of Naples Federico II","ror":"https://ror.org/05290cv24","country_code":"IT","type":"education","lineage":["https://openalex.org/I71267560"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"P. Rubba","raw_affiliation_strings":["Institute of Internal Medicine and Metabolic Disease, Clinica Medica II, 2nd Faculty of Medicine, University of Naples, Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Internal Medicine and Metabolic Disease, Clinica Medica II, 2nd Faculty of Medicine, University of Naples, Naples, Italy","institution_ids":["https://openalex.org/I71267560"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111647521","display_name":"Francesco Lamenza","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I71267560","display_name":"University of Naples Federico II","ror":"https://ror.org/05290cv24","country_code":"IT","type":"education","lineage":["https://openalex.org/I71267560"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"F. Lamenza","raw_affiliation_strings":["Institute of Internal Medicine and Metabolic Disease, Clinica Medica II, 2nd Faculty of Medicine, University of Naples, Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Internal Medicine and Metabolic Disease, Clinica Medica II, 2nd Faculty of Medicine, University of Naples, Naples, Italy","institution_ids":["https://openalex.org/I71267560"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021285480","display_name":"Silvana Montefusco","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I71267560","display_name":"University of Naples Federico II","ror":"https://ror.org/05290cv24","country_code":"IT","type":"education","lineage":["https://openalex.org/I71267560"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"S. Montefusco","raw_affiliation_strings":["Institute of Internal Medicine and Metabolic Disease, Clinica Medica II, 2nd Faculty of Medicine, University of Naples, Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Internal Medicine and Metabolic Disease, Clinica Medica II, 2nd Faculty of Medicine, University of Naples, Naples, Italy","institution_ids":["https://openalex.org/I71267560"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5074379697","display_name":"Paolo Mastranzo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I71267560","display_name":"University of Naples Federico II","ror":"https://ror.org/05290cv24","country_code":"IT","type":"education","lineage":["https://openalex.org/I71267560"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"P. Mastranzo","raw_affiliation_strings":["Institute of Internal Medicine and Metabolic Disease, Clinica Medica II, 2nd Faculty of Medicine, University of Naples, Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Internal Medicine and Metabolic Disease, Clinica Medica II, 2nd Faculty of Medicine, University of Naples, Naples, Italy","institution_ids":["https://openalex.org/I71267560"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I71267560"],"apc_list":null,"apc_paid":null,"fwci":0.3445,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.58363947,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"16","issue":"1","first_page":"1","last_page":"8"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13430","display_name":"Lipid metabolism and disorders","score":0.989300012588501,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T13430","display_name":"Lipid metabolism and disorders","score":0.989300012588501,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.008999999612569809,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mesoglycan","display_name":"mesoglycan","score":0.9940000176429749},{"id":"https://openalex.org/keywords/oral-administration","display_name":"oral administration","score":0.6539999842643738},{"id":"https://openalex.org/keywords/primary-hyperlipoproteinemia","display_name":"primary hyperlipoproteinemia","score":0.8970000147819519},{"id":"https://openalex.org/keywords/lipoprotein-lipase-activity","display_name":"lipoprotein lipase activity","score":0.9259999990463257},{"id":"https://openalex.org/keywords/plasma-lipoproteins","display_name":"serum lipoproteins","score":0.8899999856948853},{"id":"https://openalex.org/keywords/hypertriglyceridemia","display_name":"hypertriglyceridemia","score":0.906000018119812},{"id":"https://openalex.org/keywords/vldl-triglycerides","display_name":"VLDL triglycerides","score":0.9010000228881836},{"id":"https://openalex.org/keywords/type-iv-hyperlipoproteinemia","display_name":"type IV hyperlipoproteinemia","score":0.921999990940094},{"id":"https://openalex.org/keywords/type-v-hyperlipoproteinemia","display_name":"type V hyperlipoproteinemia","score":0.9390000104904175},{"id":"https://openalex.org/keywords/type-i-hyperlipoproteinemia","display_name":"type I hyperlipoproteinemia","score":0.7900000214576721}],"concepts":[{"id":"https://openalex.org/C94879076","wikidata":"https://www.wikidata.org/wiki/Q420014","display_name":"Lipoprotein lipase","level":3,"score":0.7796627879142761},{"id":"https://openalex.org/C8243546","wikidata":"https://www.wikidata.org/wiki/Q419074","display_name":"Very low-density lipoprotein","level":4,"score":0.7060900926589966},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6679783463478088},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5828161835670471},{"id":"https://openalex.org/C2778913445","wikidata":"https://www.wikidata.org/wiki/Q186319","display_name":"Triglyceride","level":3,"score":0.5807377696037292},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4971010982990265},{"id":"https://openalex.org/C2780072125","wikidata":"https://www.wikidata.org/wiki/Q28350","display_name":"Lipoprotein","level":3,"score":0.49469849467277527},{"id":"https://openalex.org/C2993401043","wikidata":"https://www.wikidata.org/wiki/Q28350","display_name":"Plasma lipoprotein","level":4,"score":0.4806841313838959},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4627964496612549},{"id":"https://openalex.org/C2779697368","wikidata":"https://www.wikidata.org/wiki/Q380967","display_name":"Lipase","level":3,"score":0.41331157088279724},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.30514848232269287},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.19675999879837036},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.14856719970703125},{"id":"https://openalex.org/C171089720","wikidata":"https://www.wikidata.org/wiki/Q193583","display_name":"Adipose tissue","level":2,"score":0.041425853967666626}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006025","descriptor_name":"Glycosaminoglycans","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006938","descriptor_name":"Hyperlipoproteinemia Type II","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006953","descriptor_name":"Hyperlipoproteinemia Type IV","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008071","descriptor_name":"Lipoprotein Lipase","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D008074","descriptor_name":"Lipoproteins","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/s0031-6989(84)80099-5","doi":"https://doi.org/10.1016/s0031-6989(84)80099-5","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0031-6989(84)80099-5","pdf_url":null,"source":{"id":"https://openalex.org/S129439886","display_name":"Pharmacological Research Communications","issn_l":"0031-6989","issn":["0031-6989","1879-2936"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310319955","host_organization_name":"Academic Press","host_organization_lineage":["https://openalex.org/P4310319955","https://openalex.org/P4310320990"],"host_organization_lineage_names":["Academic Press","Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacological Research Communications","raw_type":"journal-article"},{"id":"pmid:6230680","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/6230680","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacological research communications","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":12,"referenced_works":["https://openalex.org/W345914712","https://openalex.org/W574112097","https://openalex.org/W1968507126","https://openalex.org/W1968541049","https://openalex.org/W1990551850","https://openalex.org/W2006842172","https://openalex.org/W2016421769","https://openalex.org/W2032120179","https://openalex.org/W2071501808","https://openalex.org/W2093705010","https://openalex.org/W2304427329","https://openalex.org/W4250397692"],"related_works":["https://openalex.org/W1968507126","https://openalex.org/W7018786267","https://openalex.org/W2016239264","https://openalex.org/W2080687603","https://openalex.org/W2086646885","https://openalex.org/W1969186179","https://openalex.org/W2465737674","https://openalex.org/W204866630","https://openalex.org/W1980628104","https://openalex.org/W2397109979"],"abstract_inverted_index":null,"counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}